Related references
Note: Only part of the references are listed.Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure
Sarah Waliany et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
LAG3's Enigmatic Mechanism of Action
Colin G. Graydon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Myocarditis: endomyocardial biopsy and circulating anti-heart autoantibodies are key to diagnosis and personalized etiology-directed treatment
Alida L. P. Caforio
EUROPEAN HEART JOURNAL (2021)
Pathological and clinical effects of interleukin-6 on human myocarditis
Naofumi Amioka et al.
JOURNAL OF CARDIOLOGY (2021)
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves' Disease
Ziyi Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis
Rafael Blanco-Dominguez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors
Sarah Waliany et al.
JACC: CARDIOONCOLOGY (2021)
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity JACC: CardioOncology Primer
Lili Zhang et al.
JACC: CARDIOONCOLOGY (2021)
CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes
Mirjana Efremova et al.
NATURE PROTOCOLS (2020)
Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation
Mariella Bockstahler et al.
CIRCULATION (2020)
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Adrienne M. Luoma et al.
CELL (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
High-Parameter Single-Cell Analysis
Pratip K. Chattopadhyay et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 12 (2019)
T cell checkpoint regulators in the heart
Nir Grabie et al.
CARDIOVASCULAR RESEARCH (2019)
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials
Ramy Gadalla et al.
FRONTIERS IN ONCOLOGY (2019)
Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell
Masaru Takeshita et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
Joe-Elie Salem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Opposing T cell responses in experimental autoimmune encephalomyelitis
Naresha Saligrama et al.
NATURE (2019)
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis
Yoshito Zamami et al.
JAMA ONCOLOGY (2019)
Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease
Peter A. Szabo et al.
NATURE COMMUNICATIONS (2019)
The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system
Adriana Tomic et al.
SCIENTIFIC DATA (2019)
KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity
Dietmar Herndler-Brandstetter et al.
IMMUNITY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Javid J. Moslehi et al.
LANCET (2018)
NKG2D: A Master Regulator of Immune Cell Responsiveness
Felix M. Wensveen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C. Arbour et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
Mehdi Touat et al.
NEUROLOGY (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Eoin F. McKinney et al.
NATURE (2015)
Chemokine-Chemokine Receptor CCL2-CCR2 and CX3CL1-CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis
Motoko Sasaki et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Gender differences in myocarditis: a nationwide study in Finland
V. Kyto et al.
EUROPEAN HEART JOURNAL (2014)
Linking T-cell receptor sequence to functional phenotype at the single-cell level
Arnold Han et al.
NATURE BIOTECHNOLOGY (2014)
CCR5 Inhibition Prevents Cardiac Dysfunction in the SIV/Macaque Model of HIV
Kathleen M. Kelly et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Targeting CCL5 in inflammation
Rafael Elias Marques et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
The heart of the matter: Protection of the myocardium from T cells
Andrew H. Lichtman
JOURNAL OF AUTOIMMUNITY (2013)
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
Esther Bandala-Sanchez et al.
NATURE IMMUNOLOGY (2013)
Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8+ T Cell Phenotypes
Evan W. Newell et al.
IMMUNITY (2012)
PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
Margarite L. Tarrio et al.
JOURNAL OF IMMUNOLOGY (2012)
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
Sean C. Bendall et al.
SCIENCE (2011)
A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection
Alison Crawford et al.
PLOS PATHOGENS (2011)
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
Jian Wang et al.
INTERNATIONAL IMMUNOLOGY (2010)
KLRG1-more than a marker for T cell senescence
Sian M. Henson et al.
AGE (2009)
CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi
FS Machado et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis
N Grabie et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
JK Damås et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
